| Literature DB >> 25560411 |
Yixia Zhao1, Hui Guo1, Guilin Qiao2, Mark Zucker1, Wallace Y Langdon3, Jian Zhang4.
Abstract
CD28 costimulation is essential for the development of thymic-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells ("tTregs"). E3 ubiquitin ligase Cbl-b has been shown to regulate CD28 dependence of T cell activation. In this paper, we report that the loss of Cbl-b partially but significantly rescues the defective development of tTregs in Cd28(-/-) mice. This partial rescue is independent of IL-2. Mechanistically, Cbl-b binds to Foxp3 upon TCR stimulation and, together with Stub1, targets Foxp3 for ubiquitination and subsequently degradation in the proteasome. As Cbl-b self-ubiquitination and proteasomal degradation is impaired in Cd28(-/-) T cells, the defective development of tTregs in Cd28(-/-) mice may in part be due to increased Foxp3 ubiquitination and degradation targeted by Stub1 and Cbl-b. Treating Cd28(-/-) mice with a proteasome inhibitor completely rescues defective tTreg development in these mice. Therefore, Cbl-b, together with Stub1, ubiquitinate Foxp3, and regulate tTreg development.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25560411 PMCID: PMC4324371 DOI: 10.4049/jimmunol.1402434
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422